Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives
Moriteru Asano(Takeda (Japan)), Atsushi Hasuoka(Takeda (Japan)), Masami Yamada(National Defense Academy of Japan), Takashi Santou(Takeda (Japan)), Noriyuki Habuka, Takenori Hitaka(Takeda (Japan)), Jason K. Yano(Fleet Science Center), Megumi Morimoto(Takeda (Japan)), Hiromi Shinohara(Takeda (Japan)), Takahito Hara(Takeda (Japan)), Takashi Imada(Takeda (Japan)), Keith P. Wilson(University of Alabama at Birmingham), Yumi Imai(University of Iowa), Masuo Yamaoka, Hisashi Fujita
Cited by 20
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Cl–π interactions in protein–ligand complexes
|Protein Science|2008|213
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172